OBSERVATIONS ON THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH MYCOSIS FUNGOIDES.
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002219:Carbamates; D002699:Chlorambucil; D003609:Dactinomycin; D004358:Drug Therapy; D005472:Fluorouracil; D006801:Humans; D008727:Methotrexate; D016685:Mitomycin; D008937:Mitomycins; D009182:Mycosis Fungoides; D009369:Neoplasms; D010166:Palliative Care; D012878:Skin Neoplasms; D013852:Thiotepa; D046509:Tissue Culture Techniques; D014747:Vinblastine
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002219:Carbamates; D008937:Mitomycins; D002699:Chlorambucil; D003609:Dactinomycin; D016685:Mitomycin; D014747:Vinblastine; D013852:Thiotepa; D005472:Fluorouracil; D008727:Methotrexate
ACTINOMYCIN; ALKYLATING AGENTS; ANTIBIOTICS; ANTINEOPLASTIC AGENTS; CARBAMATES; CHLORAMBUCIL; DRUG THERAPY; FLUOROURACIL; METHOTREXATE; MITOMYCIN; MYCOSIS FUNGOIDES; PALLIATIVE TREATMENT; SKIN NEOPLASMS; THIO-TEPA; TISSUE CULTURE; VINBLASTINE